Coronary Artery Disease Clinical Trials in The Bronx, New York

6 studies are recruiting for coronary artery disease in The Bronx, New York right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

1. Pivotal Study of the SUpira System in Patients Undergoing High-Risk Percutaneous COronaRy InTervention (HRPCI)

   The objective of this study is to assess the safety and efficacy of the Supira System in providing temporary cardiovascular hemodynamic support in patients undergoing HRPCI. Eligible patients will be randomized to undergo HRPCI with either the Supira System (investigational device) or the commercia…

   Stage

   Not phased

   Ages

   18 to 90

   Site

   Montefiore Medical Center, The Bronx, New York

   Locations

   19 in total

   Run by

   Supira Medical

   See if you can join NCT07296744 on ClinicalTrials.gov

2. CTSN Embolic Protection Trial

   This is a prospective, multi-center, randomized effectiveness trial of the CardioGard Embolic Protection Cannula in high-risk valve surgery patients.

   Stage

   Not phased

   Ages

   60 and older

   Site

   Montefiore Medical Center, The Bronx, New York

   Locations

   28 in total

   Run by

   Icahn School of Medicine at Mount Sinai

   See if you can join NCT06027788 on ClinicalTrials.gov

3. MagicTouch™Sirolimus-Coated Balloon for Treatment of Coronary Artery Lesions in Small Vessels

   This is a multicenter, randomized, single-blind pivotal study to evaluate the safety and efficacy of the MagicTouchTM Drug coated balloon in treatment of small vessels in patients with coronary artery disease. The objective is to establish the safety and efficacy of the Magic TouchTM Drug coated ba…

   Stage

   Not phased

   Ages

   18 to 80

   Site

   Montefiore Medical Center, The Bronx, New York

   Locations

   24 in total

   Run by

   Concept Medical Inc.

   See if you can join NCT06271590 on ClinicalTrials.gov

4. Staged Complete Revascularization for Coronary Artery Disease vs Medical Management Alone in Patients With AS Undergoing Transcatheter Aortic Valve Replacement

   Patients undergoing transcatheter aortic valve replacement (TAVR) often have concomitant coronary artery disease (CAD) which may adversely affect prognosis. There is uncertainty about the benefits and the optimal timing of revascularization for such patients. There is currently clinical equipoise r…

   Stage

   Not phased

   Ages

   Any age

   Site

   Montefiore Medical Center, The Bronx, New York

   Locations

   72 in total

   Run by

   University of British Columbia

   See if you can join NCT04634240 on ClinicalTrials.gov

5. Physiology-guided vs Angiography-guided Non-culprit Lesion Complete Revascularization for Acute MI & Multivessel Disease

   COMPLETE-2 is a prospective, multi-centre, randomized controlled trial comparing a strategy of physiology-guided complete revascularization to angiography-guided complete revascularization in patients with acute ST-segment elevation myocardial infarction (STEMI) or non-ST-segment elevation myocardi…

   Stage

   Not phased

   Ages

   18 and older

   Site

   Montefiore Medical Center, The Bronx, New York

   Locations

   113 in total

   Run by

   Population Health Research Institute

   See if you can join NCT05701358 on ClinicalTrials.gov

6. MagicTouch for Treatment of In-Stent Restenosis in Coronary Artery Lesions

   A Prospective, Multicenter, Randomized, Two-Arm, Single-blind Superiority Trial to Evaluate the Safety and Efficacy of the MagicTouch™ Sirolimus- Coated Balloon in the Treatment of Coronary Drug-Eluting Stent In-Stent Restenosis. Subjects with prior DES implantation presenting with ISR lesions unde…

   Stage

   Not phased

   Ages

   18 to 110

   Site

   Montefiore Medical Center - Moses Division, The Bronx, New York

   Locations

   28 in total

   Run by

   Concept Medical Inc.

   See if you can join NCT05908331 on ClinicalTrials.gov